Are you a patient?

Novel mode of action

ENTRESTO simultaneously enhances the beneficial vasculatory effects of the natriuretic peptide system whilst inhibiting the detrimental effects of the renin–angiotensin–aldosterone system.1

.

 

Reference

  1. Vardeny O, et al. Combined neprilysin and renin-angiotensin system inhibition for the treatment of heart failure CME. J Am Coll Cardiol Heart Fail 2014;2(6):663–670.

Date of preparation: July 2016 ENT16-C022c(1)